ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS

Purpose of research. To analyze reproductive outcomes and relapses of endometriosis in women after surgical treatment of colorectal endometriosis depending on hormonal therapy.Materials and methods. The article includes data on reproductive outcomes and recurrence of endometriosis in women undergoin...

Full description

Bibliographic Details
Main Authors: E. V. Lisovskaya, V. D. Chuprynin
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-09-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2604
_version_ 1797841428741619712
author E. V. Lisovskaya
V. D. Chuprynin
author_facet E. V. Lisovskaya
V. D. Chuprynin
author_sort E. V. Lisovskaya
collection DOAJ
description Purpose of research. To analyze reproductive outcomes and relapses of endometriosis in women after surgical treatment of colorectal endometriosis depending on hormonal therapy.Materials and methods. The article includes data on reproductive outcomes and recurrence of endometriosis in women undergoing surgical treatment for colorectal endometriosis in the surgical department of Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology from 2014 to 2016. As an anti-relapse therapy, the first group of women received dienogest (DNG) at a dose of 2 mg/day, the second group included women who received a combined oral contraceptive containing DNG 2 mg + ethinyl estradiol (EE) 0.03 mg for the period of rehabilitation or prior to planning of pregnancy. The comparison group consisted of women who did not receive hormonal drugs in the postoperative period. Data on side effects and tolerability of the drug are also described.Results. During the follow up period from 12 to 48 months, 51 patients were selected for this study, 14 patients were included in the first group, 18 patients were in the second group, 19 patients were in the comparison group. There were no differences in the overall rate of pregnancy depending on the choice of tactics of postoperative management. The highest number of pregnancies (92.3%) occurred during the first year after surgery, which suggests the effect of the duration of hormone therapy on the probability of pregnancy. The lowest number of relapses was registered in the group of long-term monotherapy of DNG. In the group of DNG monotherapy a greater number of side effects were noted, which in most cases did not cause significant discomfort to patients.Conclusion. Long-term administration of DNG at a dose of 2 mg/day after surgical treatment of colorectal endometriosis is an effective means of preventing relapses with good tolerability. However, in some women planning a pregnancy, it may be rational to abandon hormone therapy in favor of earlier pregnancy planning.
first_indexed 2024-04-09T16:30:39Z
format Article
id doaj.art-5e494cb643ac49bca65153e0b34eb19e
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:30:39Z
publishDate 2018-09-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-5e494cb643ac49bca65153e0b34eb19e2023-04-23T06:57:06ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-09-01013576010.21518/2079-701X-2018-13-57-602558ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSISE. V. Lisovskaya0V. D. Chuprynin1Kulakov National Medical Research Centre for Obstetrics, Gynaecology and PerinatologyKulakov National Medical Research Centre for Obstetrics, Gynaecology and PerinatologyPurpose of research. To analyze reproductive outcomes and relapses of endometriosis in women after surgical treatment of colorectal endometriosis depending on hormonal therapy.Materials and methods. The article includes data on reproductive outcomes and recurrence of endometriosis in women undergoing surgical treatment for colorectal endometriosis in the surgical department of Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology from 2014 to 2016. As an anti-relapse therapy, the first group of women received dienogest (DNG) at a dose of 2 mg/day, the second group included women who received a combined oral contraceptive containing DNG 2 mg + ethinyl estradiol (EE) 0.03 mg for the period of rehabilitation or prior to planning of pregnancy. The comparison group consisted of women who did not receive hormonal drugs in the postoperative period. Data on side effects and tolerability of the drug are also described.Results. During the follow up period from 12 to 48 months, 51 patients were selected for this study, 14 patients were included in the first group, 18 patients were in the second group, 19 patients were in the comparison group. There were no differences in the overall rate of pregnancy depending on the choice of tactics of postoperative management. The highest number of pregnancies (92.3%) occurred during the first year after surgery, which suggests the effect of the duration of hormone therapy on the probability of pregnancy. The lowest number of relapses was registered in the group of long-term monotherapy of DNG. In the group of DNG monotherapy a greater number of side effects were noted, which in most cases did not cause significant discomfort to patients.Conclusion. Long-term administration of DNG at a dose of 2 mg/day after surgical treatment of colorectal endometriosis is an effective means of preventing relapses with good tolerability. However, in some women planning a pregnancy, it may be rational to abandon hormone therapy in favor of earlier pregnancy planning.https://www.med-sovet.pro/jour/article/view/2604colorectal endometriosissurgical treatmentreproductive outcomesanti-relapse therapy
spellingShingle E. V. Lisovskaya
V. D. Chuprynin
ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
Медицинский совет
colorectal endometriosis
surgical treatment
reproductive outcomes
anti-relapse therapy
title ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
title_full ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
title_fullStr ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
title_full_unstemmed ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
title_short ASSESSMENT OF EFFICIENCY OF ANTI-RELAPSE THERAPY WITH DIENOGEST AFTER SURGERY TREATMENT OF WOMEN WITH COLORECTAL ENDOMETRIOSIS
title_sort assessment of efficiency of anti relapse therapy with dienogest after surgery treatment of women with colorectal endometriosis
topic colorectal endometriosis
surgical treatment
reproductive outcomes
anti-relapse therapy
url https://www.med-sovet.pro/jour/article/view/2604
work_keys_str_mv AT evlisovskaya assessmentofefficiencyofantirelapsetherapywithdienogestaftersurgerytreatmentofwomenwithcolorectalendometriosis
AT vdchuprynin assessmentofefficiencyofantirelapsetherapywithdienogestaftersurgerytreatmentofwomenwithcolorectalendometriosis